Chromosome Disorders  >>  lenalidomide  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lenalidomide / Generic mfg.
NCT00179621 / 2005-000454-73: Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality

Completed
3
205
Europe, RoW
Lenalidomide 5 mg, Revlimid, Lenalidomide 10 mg, Placebo
Celgene Corporation, ICON Clinical Research
Myelodysplastic Syndromes
06/08
06/10

Download Options